Summary
A combination of trimethoprim (TMP) and sulfamethopyrazine (SMP) was administered to six healthy volunteers for 8 days, according to the proposed therapeutic repeated dose schedule. The weak base TMP (pKa=7.3) and the weak acid SMP (pKa=6.1) were measured simultaneously in serum and saliva, both under normal conditions and after stimulation of saliva flow. The flow of saliva was stimulated by chewing plastic material in order to obtain saliva at a pH close to the normal plasma pH of 7.4. This procedure excluded pH-dependent distribution effects. Under these experimental conditions a highly significant correlation was observed between the serum and saliva concentrations of both drugs, with very small inter- and intraindividual variations. Substantial agreement was found between the saliva:serum concentration ratio and the fractions of both drugs not bound to plasma protein. Some discrepancies were noted, probably due to minor shifts in saliva pH during the collection period.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bratton AC, Marshall EK (1939) A new coupling component for sulfanilamide determination. J Biol Chem 128: 537–550
Bushby SRM, Hitchings GH (1968) Trimethoprim, a sulphonamide potentiator. Br J Pharmacol 33: 72–90
Cook CE, Amerson E, Poole WK, Lesser P, O'Tuama L (1975) Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmuno assay. Clin Pharmacol Ther 18: 742–747
Dawes C, Jenkins GN (1964) The effects of different stimuli on the composition of saliva in man. J Physiol 170: 86–100
Dvorchik BH, Vesell ES (1976) Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clin Chem 22: 868–878
Eatman FB, Maggio AC, Pocelinko R, Boxenhaum HG, Geitner KA, Glover W, Macasieb T, Holazo A, Weinfeld RE, Kaplan SA (1977) Blood and salivary concentrations of sulfamethoxazole and trimethoprim in man. J Pharmacokin Biopharm 5: 615–624
Glynn JP, Bastain W (1973) Salivary excretion of paracetamol in man. J Pharm Pharmacol 25: 420–421
Grüneisen A, Witzgall H (1974) Abhängigkeit der Speichel-konzentration körperfremder Stoffe von der Blutwasserkonzentration an dem Modell von fünf Sulfamiden. Eur J Clin Pharmacol 7: 77–79
Huffman DH (1975) Relationship between digoxin concentrations in serum and saliva. Clin Pharmacol Ther 17: 310–312
Inaba T, Kalow W (1975) Salivary excretion of amobarbital in man. Clin Pharmacol Ther 18: 558–562
Killman SA, Thaysen JH (1955) The permeability of the human parotid gland to a series of sulfonamide compounds, para amino-hippurate and inuline. Scand J Clin Lab Invest 7: 86–91
Koysooko R, Ellis EF, Levy G (1974) Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther 15: 454–460
Matin SB, Wan SH, Karam JH (1974) Pharmacokinetics of tolbutamide: prediction by concentration in saliva. Clin Pharmacol Ther 16: 1052–1058
Mucklow JC, Bending MR, Kahn GC, Dollery CT (1978) Drug concentration in saliva. Clin Pharmacol Ther 24: 563–570
Reeves DS, Bywater MJ, Bullock DW, Holt HA (1980) Pharmacokinetic study of a sulfamethopyrazine/trimethoprim combination (Kelfiprim) in human volunteers. J Antimicrob Chemother 6: 647–656
Rieder J (1972) Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids. Chemotherapy 17: 1–21
Vesell ES, Passananti GT, Glewright PA, Dvorchik BH (1975) Studies on the disposition of antipyrine, aminopyrine and phenacetin using plasma, saliva and urine. Clin Pharmacol Ther 18: 259–272
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sardi, A., Vettaro, M.P., Alesina, R. et al. Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man. Eur J Clin Pharmacol 20, 113–118 (1981). https://doi.org/10.1007/BF00607146
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607146